Heterotopic pancreas is defined as histologically identifiable pancreatic tissue not located in or connected to the pancreas. It was first reported in 1727, when Jean Schultz noted pancreatic tissue in an ileal diverticulum1. The heterotopic tissue is believed to separate from the pancreas during embryonic rotation and fusion of the dorsal and ventral pancreatic buds2. Pathological processes usually associated with the normally placed pancreas can occur in this ectopic tissue. We report a case that highlights the diagnostic dilemma that can arise in patients with a heterotopic pancreas.
CASE HISTORY
A 19-year-old male presented with a 4-week history of epigastric pain, anorexia, postprandial bilious vomiting and weight loss. He smoked 20 cigarettes per day and drank 60 units of alcohol per week. He was tachycardic but normotensive, and had a generally tender abdomen. The Ranson criteria3 for acute pancreatitis were absent but the serum amylase was raised at 503 international units. Conservative management was implemented for a presumptive diagnosis of pancreatitis.
Ultrasound examination demonstrated a normal pancreas, a small volume of free intraperitoneal fluid and a fluid collection related to the lesser omentum. Endoscopy revealed mild duodenitis. Contrast computed tomography confirmed an irregular 4cm fluid collection in the lesser omentum with a cluster of 2 cm lesions adjacent to it within the liver substance, consistent with haemangiomata. A labelled white cell scan established a subhepatic collection, consistent with cholecystitis, but a HIDA scan was normal. A magnetic resonance scan revealed a T2 weighted signal inferoposterior to the left lobe of the liver which had the imaging features of a pancreatic pseudocyst ( Figure 1 ). Diagnostic laparoscopy showed free bloodstained intraperitoneal fluid and a phlegmon between the liver and stomach. The gastric serosa looked normal but the stomach was not distensible with nasogastric insufflation. A liver biopsy showed sinusoidal ectasia with focal collapse of reticulin, consistent with a space occupying lesion. The Department of Surgery, Royal Naval Hospital Haslar, Gosport, Hampshire, England intraperitoneal fluid contained red blood cells and reactive mesothelial cells.
On laparotomy a complex cystic lesion was found between the lesser curve of the stomach and the liver with an associated severe inflammatory response. A limited gastric resection was performed with enucleation of the cystic lesions from the liver. The specimen consisted of a 4cm x 5 cm portion of stomach that contained a well circumscribed solid mass measuring 2.5 cm in diameter, associated with multiple cysts up to 3 mm. Microscopically the gastric submucosa was chronically inflamed and included a focus of pancreatic tissue containing dilated ducts with fibrosis and chronic inflammation. Neither the gastric mucosa nor the serosa was breached. Chronic heterotopic pancreatitis was diagnosed. COMMENT The prevalence of pancreatic tissue found incidentally at necropsy ranges from I to 14%, with a male to female ratio of 2:1. Its distribution is stomach 25% and jejunum 16%, with rarer sites including oesophageal diverticulum, mediastinal cyst, gallbladder, ampulla of Vater and Meckel's diverticulum. Lesions range in size from 2 mm to 4 cm, with those in the stomach tending to be the larger. In the stomach, 73% are found in the submucosa with 17% in muscularis mucosa and 10% in the subserosa. All specimens of heterotopic pancreas have contained exocrine tissue but only 33-68% contain islet cells1.
Most patients with heterotopic pancreas have no symptoms. Symptomatic patients usually have a vague ulcer-like pattern of features. In one series of 32 histologically documented cases of symptomatic heterotopic pancreas, none of the patients was diagnosed preopera-tively2. About half the patients underwent local excision of the abnormal tissue, the remainder having more formal resections of stomach or small intestine. Symptomatic heterotopic pancreas is uncommon and seems difficult to diagnose preoperatively4. Patients are either extensively investigated over a long period before coming to laparotomy or undergo extensive surgery to yield a histological diagnosis. Judicious use of modern non-invasive diagnostic techniques and assessment of lesions by minimally invasive techniques, as in this case, will serve to limit the extent of the surgical procedure. 12 months after his resection our patient remained symptom-free. The risk of carcinoma of the small intestine in patients with Crohn's disease ranges from 6 to 320 times that in the general populationl. Strictureplasty has become established as a safe method of treating short fibrotic strictures without resection2. However, with this procedure early carcinomas can be missed.
Occult small bowel adenocarcinoma in a

CASE HISTORY
A 37-year-old woman was diagnosed as having small bowel Crohn's disease in 1973. In 1988 a small-bowel meal showed multiple strictures in the upper to mid bowel with severely dilated areas between the strictures. To conserve the small intestine, 20 small intestinal strictureplasties were performed. 4 years later she developed recurrent colicky abdominal pain and diarrhoea. A small-bowel meal showed recurrent strictures. Laparotomy was done with a view to further strictureplasties, but instead a 45 cm segment of small bowel with multiple strictures was resected. There was no macroscopic evidence of malignancy but histology showed an area of severe dysplasia with well differentiated adenocarcinoma in one of the strictures. This extended into hypertrophied disorganized muscularis mucosa. The specimen also showed features of Crohn's disease, but none of seven lymph nodes contained tumour. COMMENT Only nine cases of small-bowel adenocarcinoma in a Crohn's stricture have been reported in English. All the patients had Crohn's disease for more than 10 years. Small-bowel adenocarcinoma arising in Crohn's disease behaves differently from that in patients without Crohn's disease. The average age of diagnosis is 48.2 years compared with 64.6 years3. Small-bowel cancers arising in Crohn's disease tend to occur distally (in the ileum in 73% of patients), in keeping with the distal distribution of the disease itself; by contrast, in patients without Crohn's disease the cancers affect the duodenum twice as commonly as jejunum and four times as commonly as ileum. In Crohn's disease 2-year cancer-free survival rate is 9% whereas in patients who develop adenocarcinoma de novo it ranges from 15 to 25%2. The dismal prognosis in Crohn's may be related to delay in diagnosis: the symptoms of Crohn's disease and cancer may be indistinguishable. 59% of all cancers complicating Crohn's disease were discovered incidentally during pathological examination of the surgical specimen. If the small bowel alone is considered, this figure rises to 70%4. There are only three previous reports of carcinoma in a stricture for which strictureplasty was planned5.
If there is any suspicion, frozen section biopsies should be performed5.
